Colorado Blood Cancer Institute ~ Hematology, Stem Cell Transplant, Immune Therapies, and Clinical Research @CBCIDocs @SarahCannonDocs @PresStLukesDenv
Dr. Nash reviewed data for autologous transplant for multiple sclerosis and announced the exciting future phase 3 study (BEAT MS) which will not use CD34 Selection and it will be done in collbration with @BMTCTN
One of our @CBCIDocs, Dr Richard Nash, discussing the use of autologous HCT in the treatment of #MultipleSclerosis and other autoimmune diseases at #BMTTandem18